Senate Joint Resolution 988, sponsored by Akbari, aims to commemorate May 2026 as ALS Awareness Month. The resolution highlights the severity of amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disease that significantly impairs a person's ability to perform basic functions such as walking, talking, and breathing. It notes the alarming statistics surrounding ALS, including the frequency of new diagnoses and the average survival time post-diagnosis, as well as the increased risk of developing ALS among military veterans. The resolution emphasizes the importance of access to therapies, medical equipment, and communication technologies for those affected by ALS, as well as the critical role of clinical trials in advancing treatment options.

Furthermore, the resolution recognizes the efforts of the ALS Association, which is the largest global philanthropic supporter of ALS research, having funded over $154 million for more than 550 projects. It calls for increased public awareness of the challenges faced by individuals living with ALS and their families, while advocating for more research funding to combat the disease. By designating May 2026 as ALS Awareness Month, the resolution seeks to honor those who contribute to ALS research and support affected individuals, fostering solidarity in the fight against this relentless disease.